<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="667">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04496141</url>
  </required_header>
  <id_info>
    <org_study_id>RC-2020-12</org_study_id>
    <nct_id>NCT04496141</nct_id>
  </id_info>
  <brief_title>Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19</brief_title>
  <official_title>Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hong Kong Sanatorium &amp; Hospital</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hong Kong Sanatorium &amp; Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Achieved serum samples of persons with or without evidence of COVID-19 infection are tested
      using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the
      immunoassays is then assessed by comparing the 2 groups of samples.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Achieved serum samples of the different testing groups are retrieved and tested with the
      immunoassays according to manufacturer's instruction.

      The test results are then compared and analyzed with statistical tests to assess the
      immunoassays'performance
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 27, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The accuracy of the different commercial SARS-CoV-2 antibody immunoassays</measure>
    <time_frame>1 month</time_frame>
    <description>To investigate the accuracy (including sensitivity, specificity, positive and negative predictive value) of the commercial SARS-CoV-2 antibody immunoassays</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>With COVID-19 infection</arm_group_label>
    <description>Subjects with a positive SARS-CoV-2 PCR</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without COVID-19 infection</arm_group_label>
    <description>Subjects with COVID-19 negative serum</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>SARS-CoV-2 antibody immunoassays</intervention_name>
    <description>Different commercial SARS-CoV-2 antibody immunoassays</description>
    <arm_group_label>With COVID-19 infection</arm_group_label>
    <arm_group_label>Without COVID-19 infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who attended clinic and had a positive SARS-CoV-2 PCR and subjects who had
        COVID-19 negative serum during the epidemic in Hong Kong.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for COVID-19 infected sera: any patient with PCR confirmed COVID-19
        infection

        Inclusion criteria for COVID-19 negative sera: sera collected after a negative SARS-CoV-2
        PCR

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonpaul Sze Tsing Zee, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hong Kong Sanatorium &amp; Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hong Kong Sanatorium &amp; Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 30, 2020</study_first_submitted>
  <study_first_submitted_qc>July 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2020</study_first_posted>
  <last_update_submitted>July 31, 2020</last_update_submitted>
  <last_update_submitted_qc>July 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hong Kong Sanatorium &amp; Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Jonpaul ST Zee</investigator_full_name>
    <investigator_title>Specialist in Infectious Disease</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

